External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience WCN 2023
Roche and Genentech at

WCN 2023

October 15 - October 19
Montreal, Canada
wcn-neurology
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
Oct 17 / Roche and Genentech
SUNFISH PARTS 1 AND 2: 4-YEAR EFFICACY AND SAFETY DATA OF RISDIPLAM▼ IN TYPES 2 AND 3 SPINAL MUSCULAR ATROPHY (SMA)
SUNFISH (NCT02908685) is a multicenter, two-part, randomized (2:1, risdiplam▼:placebo), placebo-controlled, double-blind study evaluating the efficacy and safety of risdiplam▼ in patients with Type 2 or Type 3 SMA (inclusion criteria: 2–25 years at enrollment). This presentation will report safety and efficacy data from Parts 1 and 2 of the SUNFISH study after 4 years of treatment with risdiplam▼.
Neuroscience Spinal Muscular Atrophy WCN-2023

Sign up or login to unlock the full suite of MEDICALLY features
Oct 15 / Roche and Genentech
Telemedicine Use Before and During the COVID-19 Pandemic Among People With Neurological Disorders: A Cross-Sectional Study Using US Commercial Claims Data
This cross-sectional study analyzed US PharMetrics Plus commercial claims data for telemedicine use in people with neurological disorders before and during the COVID-19 pandemic.
Neuroscience Neurodegenerative Diseases WCN-2023

Sign up or login to unlock the full suite of MEDICALLY features
Oct 15 / Roche and Genentech
Feasibility of Neurofilament Light Chain as a Blood-Based Biomarker for Screening Across Neurological Diseases
This post hoc analysis of Phase III studies of patients with different neurodegenerative diseases assessed the utility of plasma NfL levels as a biomarker using a fixed threshold for screening in clinical practice.
Neuroscience Neurodegenerative Diseases WCN-2023
01:00 PM
Duration 5mins Montreal, Canada
Telemedicine Use Before and During the COVID-19 Pandemic Among People With Neurological Disorders: A Cross-Sectional Study Using US Commercial Claims Data
Anisha M Patel, Robert Schuldt, Denise M Boudreau, Nikki Win, Bryan R Cobb, Marisa McGinley
Neuroscience | Neurodegenerative Diseases

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins Montreal, Canada
Feasibility of Neurofilament Light Chain as a Blood-Based Biomarker for Screening Across Neurological Diseases
Briana Cameron, Anisha M. Patel, Bryan R. Cobb, Ivonne Suridjan, Nikki Win
Neuroscience | Neurodegenerative Diseases

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:13 PM
Duration 13mins Hall 520C
SUNFISH PARTS 1 AND 2: 4-YEAR EFFICACY AND SAFETY DATA OF RISDIPLAM▼ IN TYPES 2 AND 3 SPINAL MUSCULAR ATROPHY (SMA)
M Oskoui, N Deconinck, ES Mazzone, A Nascimento, JW Day, K Saito, C Vuillerot, G Baranello, O Boespflug-Tanguy, N Goemans, J Kirschner, A Kostera-Pruszczyk, L Servais, J Braid, M Gerber, K Gorni, C Martin, WY Yeung, RS Scalco, E Mercuri, on behalf of the SUNFISH Study Group
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.